Feed 1093.HK
10
CSPC Pharmaceutical Group Limited 1093.HK HKSE · Healthcare · China
$8.03 -4.41% -$0.37
Depth
- Market cap
- ¥81.2B
- Enterprise value
- ¥71.9B
- P/E
- 11.1x
- Forward P/E
- 10.9x
- PEG
- -
- P/S
- 2.6x
- P/FCF
- 6.7x
- EV/EBITDA
- 7.2x
- ROIC
- 17.3%
- Gross margin
- 71.9%
- Net margin
- 23.7%
- Dividend yield
- 3.94%
- Payout ratio
- 43.7%
- Net debt/EBITDA
- -0.9x
- Beta
- 0.74
- Free float
- 66.9%
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Lei Cai
Employees
18,626
Headquarters
Shijiazhuang
Valuation
Is today's price reasonable?
- What speaks for it: The share price is below the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What to watch: Revenue fell by 7.1% a year over the last 3 years.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 CNY of revenue, 24 CNY is left as net profit.
- What speaks for it: It earns 17 CNY a year on every 100 CNY of invested capital.
Financial health
Can it carry its debt?
- What speaks for it: It holds more cash than debt: ¥10.00B against ¥652.4M.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number